This topic contains a solution. Click here to go to the answer

Author Question: Which of the following is a negative acute-phase protein? a. Prealbumin b. Interleukin-1 c. ... (Read 88 times)

swpotter12

  • Hero Member
  • *****
  • Posts: 527
Which of the following is a negative acute-phase protein?
 a. Prealbumin
  b. Interleukin-1
  c. Fibronectin
  d. C-reactive protein

Question 2

Females are more likely to have immune-deficiencies because many such deficiencies involve recessive genes, often on the Y chromosome.
 a. True
  b. False
  Indicate whether the statement is true or false



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

janeli1

  • Sr. Member
  • ****
  • Posts: 330
Answer to Question 1

a

Answer to Question 2

False



swpotter12

  • Hero Member
  • *****
  • Posts: 527
Both answers were spot on, thank you once again



janeli1

  • Sr. Member
  • ****
  • Posts: 330

 

Did you know?

Elderly adults are at greatest risk of stroke and myocardial infarction and have the most to gain from prophylaxis. Patients ages 60 to 80 years with blood pressures above 160/90 mm Hg should benefit from antihypertensive treatment.

Did you know?

Though methadone is often used to treat dependency on other opioids, the drug itself can be abused. Crushing or snorting methadone can achieve the opiate "rush" desired by addicts. Improper use such as these can lead to a dangerous dependency on methadone. This drug now accounts for nearly one-third of opioid-related deaths.

Did you know?

More than 50% of American adults have oral herpes, which is commonly known as "cold sores" or "fever blisters." The herpes virus can be active on the skin surface without showing any signs or causing any symptoms.

Did you know?

Patients who cannot swallow may receive nutrition via a parenteral route—usually, a catheter is inserted through the chest into a large vein going into the heart.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library